Precision Oncology: Emerging Technologies & Implementation

EMPIRI Inc.
Apr 8
1 min read

January 12-15, 2025 | Beaver Run Conference Center, Breckenridge, CO, USA

Dr. Kyuson Yun, Co-Founder, EMPIRI, Inc.

Recent Posts

EMPIRI Inc. Receives $2.594 Million CPRIT Grant to Advance Immunotherapy Response Prediction

HOUSTON, Texas – Nov. 19, 2025 – EMPIRI Inc., the pioneering company behind E-slice, today received a $2.594 million grant from the Cancer Prevention & Research Institute of Texas (CPRIT). This grant

EMPIRI, Inc. Selected into the 2025 BioTools Innovator Cohort

We are incredibly honored to be named one of just 31 companies in the prestigious BioTools Innovator 2025 cohort, selected from over 420 applicants worldwide! This highly competitive program, run by

EMPIRI Co-founder Dr. Kyuson Yun Named as a 2025 Beneficiary in Men of Distinction Program, Benefiting Medical Research and Treatment for Children

EMPIRI INC.

Precision Oncology: Emerging Technologies & Implementation

Recent Posts

Comments